Updates on management of gliomas in the molecular age
作者机构:Charles E.Schmidt College of MedicineFlorida Atlantic UniversityBoca RatonFL 33431United States Herbert Wertheim College of MedicineFlorida International UniversityMiamiFL 33199United States College of Osteopathic MedicineKansas City UniversityJoplinMO 64804United States Department of NeurosurgeryUniversity of FloridaGainesvilleFL 32611United States
出 版 物:《World Journal of Clinical Oncology》 (世界临床肿瘤学杂志(英文版))
年 卷 期:2024年第15卷第2期
页 面:178-194页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Gliomas Chemotherapy Radiotherapy Isocitrate dehydrogenase type mutant Pediatric gliomas Astrocytoma Oligodendroglioma 1p/19q-codeleted
摘 要:Gliomas are primary brain tumors derived from glial cells of the central nervous system,afflicting both adults and children with distinct characteristics and therapeutic *** developments have ushered in novel clinical and molecular prognostic factors,reshaping treatment paradigms based on classi-fication and grading,determined by histological attributes and cellular *** review article delves into the diverse treatment modalities tailored to the specific grades and molecular classifications of gliomas that are currently being discussed and used clinically in the year *** adults,the therapeutic triad typically consists of surgical resection,chemotherapy,and *** contrast,pediatric gliomas,due to their diversity,require a more tailored *** complete tumor excision can be curative based on the location and grade of the glioma,certain non-resectable cases demand a chemotherapy approach usually involving,vincristine and ***-tionally,if surgery or chemotherapy strategies are unsuccessful,Vinblastine can be *** recent advancements in treatment methodologies,there remains a need of exploration in the literature,particularly concerning the efficacy of treatment regimens for isocitrate dehydrogenase type mutant astrocytomas and fine-tuned therapeutic approaches tailored for pediatric *** review article explores into the therapeutic modalities employed for both adult and pediatric gliomas in the context of their molecular classification.